“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
Tag: FDA
DBV Cuts Costs Awaiting FDA; Unveils More Peanut Patch Results
With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
FDA’s Relaxed Label Rules: Updates Fail to Silence Allergy Concerns
The Food and Drug Administration recently updated its guidance on a temporary food labeling policy that has been causing widespread… Read more »
Dosing Alert Issued on Some Impax, Amneal Auto-Injectors
The FDA has issued an important alert to individuals with allergies and health-care professionals that some lots of Amneal and… Read more »
FDA’s New Label Policy Sparks Outpouring of Allergy Concerns
When she first heard the news, Mary Vargas was stunned. Like allergy parents across North America, the disability rights attorney… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Pfizer Canada Re-Issues Warning: Some EpiPens May Stick in Tube
Health Canada is warning consumers to check their EpiPen and EpiPen Jr devices – to see whether any stick in… Read more »
FDA to Review Viaskin Peanut Patch for Possible Approval
DBV Technologies has announced that the FDA has agreed to review the company’s Viaskin Peanut patch for potential regulatory approval.… Read more »
FDA Approves “Life-Changing” Biologic Drug Dupilumab for Adolescents with Severe Eczema
Painful, red eczema patches used to run up and down Benjamin Sun’s arms and legs. This severe atopic dermatitis led… Read more »